12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movement in Wednesday's intraday session. Sera Prognostics (SERA) saw a massive increase of 231.9%, while OptiNose (OPTN) led the decliners with a 22.4% drop. Other notable gainers include Phio Pharma (PHIO), Syros Pharmaceuticals (SYRS), Altimmune (ALT), Arvinas (ARVN), and Altamira Therapeutics (CYTO). On the losing side were Mira Pharmaceuticals (MIRA), InVivo Therapeutics Hldg (NVIV), Allarity Therapeutics (ALLR), GlucoTrack (GCTK), and Sonoma Pharmaceuticals (SNOA).
December 06, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
OptiNose's stock declined by 22.4% to $1.14, with a market cap of $128.0 million.
OptiNose's significant stock price decline indicates negative sentiment from investors, which could lead to further short-term downward pressure on the stock.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Altimmune's shares rose 39.94% to $7.24, with a market value of $388.7 million.
Altimmune's stock price increase reflects positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Arvinas' shares increased by 30.94% to $30.34, with a market cap of $1.6 billion.
Arvinas' significant stock price growth could indicate ongoing investor confidence, potentially leading to more short-term upward movement.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Altamira Therapeutics' shares increased by 29.69% to $0.47, with a market cap of $3.7 million.
Altamira Therapeutics' rise in stock price could suggest positive developments, possibly leading to more short-term investor interest.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Phio Pharma's shares increased by 60.36% to $1.8, with a market cap of $4.3 million.
Phio Pharma's significant rise in stock price could attract more investor attention, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Sera Prognostics' stock surged by 231.9% to $6.97, with a market cap of $218.4 million.
The substantial increase in Sera Prognostics' stock price suggests a very positive market reaction to recent news or events surrounding the company, which could lead to continued investor interest in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Syros Pharmaceuticals' stock moved upwards by 45.03% to $4.09, with a market cap of $86.1 million.
The notable increase for Syros Pharmaceuticals may continue to draw investor interest, potentially leading to further short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90